Kate Grynkiewicz
Physician Assistant · Concord, MANPI 1386256964
Payments from drug & device makers
Across 278 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$876
- AbbVie$757
- AstraZeneca$489
- Novo Nordisk$471
- Tolmar, Inc.$384
- Exact Sciences$363
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 54 | $876 |
| AbbVie | 41 | $757 |
| AstraZeneca(2 entities) | 24 | $489 |
| Novo Nordisk | 26 | $471 |
| Tolmar, Inc. | 24 | $384 |
| Exact Sciences | 14 | $363 |
| Lilly USA, LLC | 15 | $346 |
| Idorsia Pharmaceuticals US Inc | 8 | $225 |
| Johnson & Johnson | 6 | $172 |
| Corcept Therapeutics | 8 | $172 |
| Merck | 9 | $168 |
| Bausch Health US, LLC | 5 | $104 |
| Novartis | 4 | $78 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Acerus Pharmaceuticals Corporation | 4 | $69 |
| Almatica Pharma LLC | 2 | $66 |
| E.r. Squibb & Sons, L.L.C. | 2 | $59 |
| GSK | 3 | $56 |
| Scpharmaceuticals Inc. | 2 | $54 |
| Medtronic | 2 | $40 |
| Amgen | 2 | $40 |
| Eisai Inc. | 2 | $40 |
| Boehringer Ingelheim | 2 | $33 |
| SK Life Science, Inc. | 1 | $31 |
| Antares Pharma, Inc. | 1 | $30 |
| Ascensia Diabetes Care US Inc. | 1 | $27 |
| Biogen | 1 | $23 |
| Halozyme Inc | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
How this compares
$5,469 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $69,865 |
| MounjaroTirzepatide | 41 | $46,924 |
| JardianceEmpagliflozin | 44 | $41,142 |
| FarxigaDapagliflozin Propanediol | 17 | $13,172 |
| XareltoRivaroxaban | 11 | $12,186 |
| Atorvastatin Calcium | 394 | $5,267 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,035 |
| Metoprolol Succinate | 146 | $2,933 |
| VascepaIcosapent Ethyl | 12 | $2,651 |
| Lisinopril | 243 | $2,371 |
| Omeprazole | 105 | $2,121 |
| Levothyroxine Sodium | 145 | $2,062 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $1,900 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 26 | $1,891 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 82 | $1,842 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $876 | $69,86570 claims |
| Lilly USA, LLCMounjaro | $346 | $46,92441 claims |
| Boehringer IngelheimJardiance | $33 | $41,14244 claims |
| AstraZenecaFarxiga | $489 | $13,17217 claims |
| Johnson & JohnsonXarelto | $172 | $12,18611 claims |
| GSKBreo Ellipta | $56 | $5,03512 claims |
| AbbVieSynthroid | $757 | $1,61320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Other physician assistant in Concord
- Christopher MasseyWilbraham$190K
- Lizabeth O ConnorEverett$182K
- Kimberly ComeauSwampscott$120K
- Stacey PanasciSpringfield$113K
- Jason RandWaltham$99K
- Karen ChunEast Boston$70K
- David PeckhamQuincy$61K
- Leslie SmithSpringfield$49K
- Andrea MilliganBoston$46K
- Lauren RousseauBoston$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.